Cancer and climate change: the environmental impact of cancer care.
Briggs S. et al, (2021), Lancet Oncol, 22
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lee LYW. et al, (2020), Lancet Oncol, 21, 1309 - 1316
Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities
Briggs S. and Slade I., (2019), Current Genetic Medicine Reports, 7, 63 - 74
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
Law PJ. et al, (2019), Nat Commun, 10
Pattern recognition receptor polymorphisms as predictors of oxaliplatin benefit in colorectal cancer
CHURCH DN. et al, (2018), JNCI: Journal of the National Cancer Institute
Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Domingo E. et al, (2016), Lancet Gastroenterology and Hepatology
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.
Palles C. et al, (2015), Gastroenterology, 148, 367 - 378
Antiangiogenesis: Focus on colorectal cancer
Briggs S. and Midgley R., (2014), Clinical Insights: Antiangiogenesis in Cancer Therapy, 69 - 89
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Church DN. et al, (2013), Hum Mol Genet, 22, 2820 - 2828
Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
Briggs S. and Tomlinson I., (2013), J Pathol, 230, 148 - 153
The Association between Lambert-Eaton Myasthenic Syndrome and Small Cell Lung Carcinoma
Briggs EWB. et al, (2013), ImmunoTargets and Therapy, 2, 31 - 37